• Please log in or register to access this feature.

Short Report

You have full text access to this OnlineOpen article

Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trends

  1. Peter Jepsen1,†,*,
  2. Hendrik Vilstrup2,
  3. Robert E. Tarone3,
  4. Søren Friis4,
  5. Henrik Toft Sørensen1

Article first published online: 7 JUN 2007

DOI: 10.1002/ijc.22860

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 7, pages 1624–1626, 1 October 2007

Additional Information

How to Cite

Jepsen, P., Vilstrup, H., Tarone, R. E., Friis, S. and Sørensen, H. T. (2007), Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trends. Int. J. Cancer, 121: 1624–1626. doi: 10.1002/ijc.22860

Author Information

  1. 1

    Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

  2. 2

    Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, Aarhus, Denmark

  3. 3

    International Epidemiology Institute, Rockville, MD

  4. 4

    Institute of Cancer Epidemiology, The Danish Cancer Society, Copenhagen, Denmark

  1. †

    Fax: +45-89-42-48-01.

*Department of Clinical Epidemiology, Ole Worms Allé 1150, DK-8000, Aarhus C, Denmark

  1. †

    Fax: +45-89-42-48-01.

Publication History

  1. Issue published online: 24 JUL 2007
  2. Article first published online: 7 JUN 2007
  3. Manuscript Accepted: 4 APR 2007
  4. Manuscript Received: 12 MAR 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (184K)

References

  • 1
    McGlynn KA,Tsao L,Hsing AW,Devesa SS,Fraumeni JF,Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 290–6.
    Direct Link:
  • 2
    Storm HH,Engholm G. Relative survival of Danish cancer patients diagnosed 1981 to 1997 and followed to 2001. A status report. Ugeskr Laeger 2002; 164: 2855–64. (in Danish).
  • 3
    Danish National Board of Health. Cancer incidence in Denmark 2001. Copenhagen: Danish National Board of Health, 2002.
  • 4
    El-Serag HB,Davila JA,Petersen NJ,McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 817–23.
  • 5
    Surveillance Epidemiology and End Results (SEER). SEER*Stat database (software version 6.3.5): incidence – SEER 9 Registries. Bethesda, Maryland: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, 2007.
  • 6
    Storm HH,Michelsen EV,Clemmensen IH,Pihl J. The Danish Cancer Registry—history, content, quality and use. Dan Med Bull 1997; 44: 535–9.
  • 7
    El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S27–S34.
  • 8
    Armstrong GL,Alter MJ,McQuillan GM,Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777–82.
    Direct Link:
  • 9
    Armstrong GL,Wasley A,Simard EP,McQuillan GM,Kuhnert WL,Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705–14.
  • 10
    Dienstag JL. Hepatitis C: a bitter harvest. Ann Intern Med 2006; 144: 770–1.
  • 11
    McGlynn KA,Tarone RE,El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 1198–203.
  • 12
    Fattovich G,Stroffolini T,Zagni I,Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127: S35–50.
  • 13
    Goodgame B,Shaheen NJ,Galanko J,El-Serag HB. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol 2003; 98: 2535–42.
    Direct Link:
  • 14
    Davila JA,Morgan RO,Shaib Y,McGlynn KA,El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127: 1372–80.
  • 15
    Dominitz JA,Boyko EJ,Koepsell TD,Heagerty PJ,Maynard C,Sporleder JL,Stenhouse A,Kling MA,Hrushesky W,Zeilman C,Sontag S,Shah N et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41: 88–96.
    Direct Link:
  • 16
    Westh H,Worm AM,Jensen BL,Kroon S,Kvinesdal B,Nielsen CM,Wantzin P. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Infection 1993; 21: 115–17.
  • 17
    Nelsing S,Wantzin P,Skot J,Krarup E,Nielsen TL,Krarup HB,Nielsen JO. The seroprevalence of hepatitis B and C in hospitalized Danish patients. Scand J Infect Dis 1995; 27: 445–8.
  • 18
    Fisker N,Mygind LH,Krarup HB,Licht D,Georgsen J,Christensen PB. Blood borne viral infections among Danish health care workers—frequent blood exposure but low prevalence of infection. Eur J Epidemiol 2004; 19: 61–7.
  • 19
    Christensen PB. Epidemiology of hepatitis C. Ugeskr Laeger 1998; 160: 3529–32. (in Danish).
  • 20
    World Health Organization. Hepatitis C—global prevalence (update). Wkly Epidemiol Rec 1999; 74: 425–7.
  • 21
    Statens Serum Institut. Reporting of hepatitis B and C. Epi-News 2001; 6: 1–1. (in Danish).
  • 22
    Statens Serum Institut. Acute and chronic hepatitis C 2000–2001. Epi-News 2002; 43: 1–1. (in Danish).
  • 23
    Statens Serum Institut. Acute and chronic hepatitis C 2002–2003. Epi-News 2004; 8: 1–1. (in Danish).
  • 24
    Statens Serum Institut. Acute and chronic hepatitis C 2004. Epi-News 2005; 7: 1–1. (in Danish).
  • 25
    Statens Serum Institut. Acute and chronic hepatitis C 2005. Epi-News 2006; 7: 1–1. (in Danish).
  • 26
    National Institute on Alcohol Abuse and Alcoholism. Apparent per capita ethanol consumption for the United States, 1850-2004. http://www.niaaa.nih.gov/Resources/DatabaseResources/QuickFacts/AlcoholSales/consum01.htm (accessed March 5, 2007).
  • 27
    Statistics Denmark. Sales of alcohol and tobacco, subject to excises duties by type (1995–2005). http://www.statistikbanken.dk (accessed March 5, 2007).
  • 28
    Cowie CC,Rust KF,Byrd-Holt DD,Eberhardt MS,Flegal KM,Engelgau MM,Saydah SH,Williams DE,Geiss LS,Gregg EW. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999–2002. Diabetes Care 2006; 29: 1263–8.
  • 29
    Støvring H,Andersen M,Beck-Nielsen H,Green A,Vach W. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet 2003; 362: 537–8.
  • 30
    Shaib YH,Davila JA,McGlynn K,El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472–7.
  • 31
    El-Serag HB,Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000; 95: 3566–73.
    Direct Link:
  • 32
    Stokkeland K,Brandt L,Ekbom A,Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002. Hepatology 2006; 43: 500–5.
    Direct Link:
View Full Article (HTML) Get PDF (184K)